BlackRock’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-913,506
| Closed | -$1.51M | – | 5971 |
|
|
2022
Q1 | $1.51M | Sell |
913,506
-10,325
| -1% | -$17K | ﹤0.01% | 4421 |
|
|
2021
Q4 | $2.21M | Sell |
923,831
-172,997
| -16% | -$413K | ﹤0.01% | 4298 |
|
|
2021
Q3 | $5.99M | Buy |
1,096,828
+21,806
| +2% | +$119K | ﹤0.01% | 3826 |
|
|
2021
Q2 | $8M | Buy |
1,075,022
+64,659
| +6% | +$481K | ﹤0.01% | 3659 |
|
|
2021
Q1 | $8.18M | Buy |
1,010,363
+71,732
| +8% | +$581K | ﹤0.01% | 3630 |
|
|
2020
Q4 | $8.54M | Buy |
938,631
+404,988
| +76% | +$3.69M | ﹤0.01% | 3382 |
|
|
2020
Q3 | $5.91M | Sell |
533,643
-1,297
| -0.2% | -$14.4K | ﹤0.01% | 3408 |
|
|
2020
Q2 | $3.98M | Sell |
534,940
-25,651
| -5% | -$191K | ﹤0.01% | 3540 |
|
|
2020
Q1 | $3.45M | Buy |
560,591
+51,840
| +10% | +$319K | ﹤0.01% | 3422 |
|
|
2019
Q4 | $2.55M | Buy |
508,751
+255,824
| +101% | +$1.28M | ﹤0.01% | 3656 |
|
|
2019
Q3 | $1.9M | Buy |
252,927
+8,555
| +4% | +$64.4K | ﹤0.01% | 3721 |
|
|
2019
Q2 | $2.84M | Buy |
+244,372
| New | +$2.84M | ﹤0.01% | 3619 |
|